Browsing by Author "Lu, S."
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Conference Object Citation - WoS: 2Amivantamab Plus Lazertinib Vs Osimertinib in First Line, Egfr-Mutant Advanced Nsclc: Patientrelevant Outcomes From Mariposa(Elsevier Science inc, 2024) Nguyen, D.; Besse, B.; Cho, B. C.; Lee, S. -H.; Lee, K. H.; Lu, S.; Garcia Campelo, M. R.Conference Object Pod1um-304: Phase Iii Study of Retifanlimab Plus Platinum-Based Chemotherapy (Chemo) as First-Line (1l) Therapy for Nonsquamous or Squamous Metastatic Nonesmall Cell Lung Cancer (Mnsclc)(Elsevier, 2024) Lu, S.; Vynnychenko, O.; Kulyaba, Y.; Kuchava, V.; Ibrahim, A.; Moiseenko, F. V.; Bondarenko, I.
